Literature DB >> 12185249

The program of androgen-responsive genes in neoplastic prostate epithelium.

Peter S Nelson1, Nigel Clegg, Hugh Arnold, Camari Ferguson, Michael Bonham, James White, Leroy Hood, Biaoyang Lin.   

Abstract

The human prostate gland is an important target organ of androgenic hormones. Testosterone and dihydrotestosterone interact with the androgen receptor to regulate vital aspects of prostate growth and function including cellular proliferation, differentiation, apoptosis, metabolism, and secretory activity. Our objective in this study was to characterize the temporal program of transcription that reflects the cellular response to androgens and to identify specific androgen-regulated genes (ARGs) or gene networks that participate in these responses. We used cDNA microarrays representing about 20,000 distinct human genes to profile androgen-responsive transcripts in the LNCaP adenocarcinoma cell line and identified 146 genes with transcript alterations more than 3-fold. Of these, 103 encode proteins with described functional roles, and 43 represent transcripts that have yet to be characterized. Temporal gene expression profiles grouped the ARGs into four distinct cohorts. Five uncharacterized ARGs demonstrated exclusive or high expression levels in the prostate relative to other tissues studied. A search of available DNA sequence upstream of 28 ARGs identified 25 with homology to the androgen response-element consensus-binding motif. These results identify previously uncharacterized and unsuspected genes whose expression levels are directly or indirectly regulated by androgens; further, they provide a comprehensive temporal view of the transcriptional program of human androgen-responsive cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185249      PMCID: PMC129364          DOI: 10.1073/pnas.182376299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  TFIIH is negatively regulated by cdk8-containing mediator complexes.

Authors:  S Akoulitchev; S Chuikov; D Reinberg
Journal:  Nature       Date:  2000-09-07       Impact factor: 49.962

2.  Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins.

Authors:  A Lasorella; A Iavarone; M A Israel
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

3.  Comprehensive analyses of prostate gene expression: convergence of expressed sequence tag databases, transcript profiling and proteomics.

Authors:  P S Nelson; D Han; Y Rochon; G L Corthals; B Lin; A Monson; V Nguyen; B R Franza; S R Plymate; R Aebersold; L Hood
Journal:  Electrophoresis       Date:  2000-05       Impact factor: 3.535

4.  Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter.

Authors:  K B Cleutjens; C C van Eekelen; H A van der Korput; A O Brinkmann; J Trapman
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

Review 5.  Molecular biology of the androgen receptor.

Authors:  G S Prins
Journal:  Mayo Clin Proc       Date:  2000-01       Impact factor: 7.616

6.  The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4.

Authors:  I C Ho; M R Hodge; J W Rooney; L H Glimcher
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

7.  Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model.

Authors:  N Sato; M E Gleave; N Bruchovsky; P S Rennie; S L Goldenberg; P H Lange; L D Sullivan
Journal:  J Steroid Biochem Mol Biol       Date:  1996-05       Impact factor: 4.292

8.  Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer.

Authors:  M S Shurbaji; J H Kalbfleisch; T S Thurmond
Journal:  Hum Pathol       Date:  1996-09       Impact factor: 3.466

9.  Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaP.

Authors:  J E Perry; D J Tindall
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

Review 10.  Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.

Authors:  H Bonkhoff; K Remberger
Journal:  Prostate       Date:  1996-02       Impact factor: 4.104

View more
  172 in total

1.  Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Authors:  Vanessa Fritz; Zohra Benfodda; Geneviève Rodier; Corinne Henriquet; François Iborra; Christophe Avancès; Yves Allory; Alexandre de la Taille; Stéphane Culine; Hubert Blancou; Jean Paul Cristol; Françoise Michel; Claude Sardet; Lluis Fajas
Journal:  Mol Cancer Ther       Date:  2010-06-08       Impact factor: 6.261

2.  Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.

Authors:  Jeff Holzbeierlein; Priti Lal; Eva LaTulippe; Alex Smith; Jaya Satagopan; Liying Zhang; Charles Ryan; Steve Smith; Howard Scher; Peter Scardino; Victor Reuter; William L Gerald
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

3.  WebLogo: a sequence logo generator.

Authors:  Gavin E Crooks; Gary Hon; John-Marc Chandonia; Steven E Brenner
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

Review 4.  Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.

Authors:  Irwin H Gelman
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

5.  A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.

Authors:  Ji-An Liang; Li-Min Sun; Ming-Chia Lin; Shih-Ni Chang; Fung-Chang Sung; Chih-Hsin Muo; Chia-Hung Kao
Journal:  Oncologist       Date:  2012-06-20

6.  Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.

Authors:  Paula J Hurley; Robert M Hughes; Brian W Simons; Jessie Huang; Rebecca M Miller; Brian Shinder; Michael C Haffner; David Esopi; Yasunori Kimura; Javaneh Jabbari; Ashley E Ross; Nicholas Erho; Ismael A Vergara; Sheila F Faraj; Elai Davicioni; George J Netto; Srinivasan Yegnasubramanian; Steven S An; Edward M Schaeffer
Journal:  Cancer Res       Date:  2015-08-20       Impact factor: 12.701

7.  A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.

Authors:  Qianben Wang; Wei Li; X Shirley Liu; Jason S Carroll; Olli A Jänne; Erika Krasnickas Keeton; Arul M Chinnaiyan; Kenneth J Pienta; Myles Brown
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

Review 8.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

9.  Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.

Authors:  Franklin W Huang; Juan Miguel Mosquera; Andrea Garofalo; Coyin Oh; Maria Baco; Ali Amin-Mansour; Bokang Rabasha; Samira Bahl; Stephanie A Mullane; Brian D Robinson; Saud Aldubayan; Francesca Khani; Beerinder Karir; Eejung Kim; Jeremy Chimene-Weiss; Matan Hofree; Alessandro Romanel; Joseph R Osborne; Jong Wook Kim; Gissou Azabdaftari; Anna Woloszynska-Read; Karen Sfanos; Angelo M De Marzo; Francesca Demichelis; Stacey Gabriel; Eliezer M Van Allen; Jill Mesirov; Pablo Tamayo; Mark A Rubin; Isaac J Powell; Levi A Garraway
Journal:  Cancer Discov       Date:  2017-05-17       Impact factor: 39.397

10.  Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.

Authors:  Rebecca S Arnold; Carrie Q Sun; Jendai C Richards; Galina Grigoriev; Ilsa M Coleman; Peter S Nelson; Chia-Ling Hsieh; Jae K Lee; Zhiheng Xu; Andre Rogatko; Adeboye O Osunkoya; Majd Zayzafoon; Leland Chung; John A Petros
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.